Table 1.
Groups | WBC (×109/L) | RBC (×1012/L) | HGB (g/L) | PLT (×109/L) |
---|---|---|---|---|
Normal | 7.30 ± 0.75 | 9.76 ± 0.27 | 131.00 ± 4.59 | 917.10 ± 74.65 |
Model | 10.34 ± 1.40## | 8.63 ± 0.68## | 113.20 ± 6.66## | 628.50 ± 66.09## |
Positive | 8.47 ± 0.87∗∗ | 9.46 ± 0.41∗∗ | 126.70 ± 5.70∗∗ | 881.10 ± 76.87∗∗ |
Re-L | 9.40 ± 1.28 | 8.80 ± 0.58 | 118.90 ± 8.67 | 790.00 ± 97.66∗∗ |
Re-H | 8.81 ± 0.89∗∗ | 8.95 ± 0.75 | 121.10 ± 6.31∗∗ | 833.10 ± 68.04∗∗ |
Rk3-L | 9.2 ± 1.29∗ | 8.85 ± 1.02 | 122.00 ± 5.29∗∗ | 799.90 ± 72.21∗∗ |
Rk3-H | 8.51 ± 0.97∗∗ | 9.25 ± 0.59∗ | 127.40 ± 3.92∗∗a | 853.60 ± 76.65∗∗ |
Data are expressed as mean ± SD (n = 10)
##p < 0.01 as compared with the normal group. ∗∗p < 0.01 as compared with the model group. *p < 0.05 as compared with the model group. ap < 0.05 as compared with the Re-H group
CTX, cyclophosphamide; HGB, hemoglobin; PLT, platelet; RBC, red blood cell; SD, standard deviation; WBC, white blood cell